Adam D. Timmis

Early percutaneous transluminal coronary angioplasty in the management of unstable angina

This report describes the results of percutaneous transluminal coronary angioplasty in 56 patients with unstable angina. In each case diagnostic coronary angiography had demonstrated a critical proximal stenosis in a major vessel. The stenosis was successfully dilated without complication in 70% of cases. Angiographic success was reflected by the abolition of symptoms and a nonischaemic predischarge stress test in 82 and 72% of cases, respectively. Importantly, at six months follow-up 69% of these patients remained symptom free though repeat angioplasty had been necessary in 21% of cases. The in-hospital incidence of myocardial infarction and death was 7.1 and 5.4%, respectively, but during the six month follow-up period only one additional complicating event occurred. Results were particularly favourable in patients with single vessel disease, 83% of whom had successful procedures. There was one uncomplicated myocardial infarct in this subgroup but no deaths. These data indicate that percutaneous transluminal coronary angioplasty may be undertaken with relative safety in patients with unstable angina and leads to a substantial improvement in symptoms that is sustained during early follow up. The benefits of this therapeutic approach may be particularly marked in patients with single vessel disease.

Contrast perfusion echocardiography identification of area at risk of dyskinesis during percutaneous transluminal coronary angioplasty

Two-dimensional contrast perfusion echocardiography was performed in 14 patients who underwent percutaneous transluminal coronary angioplasty to test the efficacy of this new technique for defining the area at risk of dyskinesis during acute coronary occlusion. In nine patients (group A) selective coronary injection of echocontrast medium through the central lumen of the angioplasty catheter was performed immediately before balloon inflation. This produced regional myocardial enhancement that defined the area of dyskinesis after balloon inflation. In five patients (group B) who underwent left coronary angioplasty, echocontrast medium was injected through the introducer catheter positioned in the left main coronary artery during balloon inflation. In each case this produced regional myocardial enhancement remote from the area of dyskinesis. There were no complications related to the intracoronary echocontrast injections, which produced no discernible exacerbation of chest pain or left ventricular contractile dysfunction. These data indicate that selective coronary injection of echocontrast medium defines the perfusion territory of the artery injected and also provides a means of identifying the area at risk of dyskinesis after balloon occlusion of the artery.

Contrast perfusion echocardiography: Distribution and reproducibility of myocardial contrast enhancement in coronary artery disease

A qualitative assessment was undertaken of the echocardiographic distribution of myocardial contrast enhancement after selective intracoronary injections of 2 ml of hand-agitated Urografin solution. The reproducibility and duration of contrast enhancement has also been examined. Forty-five contrast injections were given, 36 into the left and 6 into the right coronary arteries and 3 into bypass grafts of 28 patients undergoing diagnostic arteriography. Myocardial contrast enhancement occurred in 91% of cases. Although contrast enhancement appeared within the expected area of distribution of the artery infused, in no case was enhancement homogeneous. In 4 patients (1 of whom had undergone coronary bypass surgery), contrast enhancement also appeared in areas remote from the expected perfusion territory, in each case due to well established collateral supply seen angiographically. The contrast effect persisted for 71 +/- 26 seconds. Repeat injection in 5 patients (using identical echocardiographic windows) confirmed the reproducibility of the technique. No patient had symptoms related to the injections, although transient left ventricular wall motion abnormalities were observed in 3 cases. High-grade coronary stenoses did not affect distribution of myocardial contrast enhancement, although coronary occlusions produced well defined deficits. Thus, selective intracoronary injections of hand-agitated echocardiographic contrast medium produce regional myocardial enhancement, which probably reflects the perfusion territory of the artery. The technique is safe and reproducible in human subjects. Nevertheless, because regional enhancement after selective coronary injections is not homogeneous, analysis of enhancement deficits is unlikely to provide a clinically useful means of evaluating the functional significance of coronary stenoses.

Myocardial infarction and biventricular free-wall rupture with shunting through a false aneurysm

A 65-year-old man presented with acute inferior myocardial infarction and received thrombolytic therapy with clinical evidence of coronary arterial recanalisation. Recovery was uncomplicated until- the eighth day when he experienced recurrent chest pain with evidence of reinfarction in the same territory. This was associated with the development of a pansystolic murmur and cardiogenic shock. Cardiac catheterisation showed right coronary arterial occlusion and inferior infarction with a false aneurysm and a left-to-right shunt (shunt ratio 2.5:1). Surgery confirmed the formation of a false aneurysm caused by rupture of the free walls of both ventricles. Importantly, however, the interventricular septum was intact and the left-to-right shunt was through the false aneurysm itself. This is the first report of biventricular free-wall rupture with shunting through a false aneurysm treated successfully by surgery.

Localized aortic dissection with rupture into the right atrium: Diagnosis by computed tomography and cardiac catheterization

Abstract Aortic dissection with rupture into the right atrium is rare. The condition usually becomes apparent either during heart surgery or at postmortem examination. 1,2 We report a patient diagnosed by computed tomography (CT) and cardiac catheterization.

An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

SummaryThis is an interim report of the initial 36 patients entered into the first double-blind, placebo-controlled invasive arteriographic study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) for coronary recanalisation in acute myocardial infarction. Coronary arteriography was performed before and 90 minutes after a single intravenous bolus injection of APSAC or placebo given over 2 to 5 minutes.Pretreatment coronary arteriography was performed in 36 patients at a mean time of 189 ± 75 minutes after the onset of symptoms. 28 patients had occluded infarct-related coronary arteries and were randomised to receive APSAC 30U (n = 15) or placebo (n = 13) by intravenous injection 195 ± 72 minutes after the onset of symptoms. Coronary arteriography 90 minutes after treatment demonstrated recanalisation of the infarct-related coronary artery in 8 APSAC-treated patients compared with only 1 placebo-treated patient (p < 0.02). Repeat coronary arteriography 3 days after treatment showed reocclusion in 1 of the 8 APSAC-treated patients and persistent perfusion in the single patient who reperfused on placebo.All patients with patent vessels at pretreatment coronary arteriography (3 APSAC, 5 placebo) remained patent throughout the study period. There were no haemorrhagic complications related to APSAC therapy. These data confirm that APSAC is a safe, effective thrombolytic agent which, when administered by the intravenous route, resulted in a 53% recanalisation rate.

Angiographic morphology of recurrent stenoses after percutaneous transluminal coronary angioplasty: are lesions longer at restenosis?

Angiographic morphology was analysed in 32 patients who developed restenosis after initially successful coronary angioplasty. The mean minimal luminal diameter of the dilated coronary segments increased from 0.9 mm to 2.3 mm after dilatation, but decreased to 0.9 mm at restenosis. The reference diameter was unchanged after dilatation and at restenosis. Mean stenosis length before the initial angioplasty was 7.0 mm but at the repeat procedure had increased to 8.7 mm (mean increase 1.7 mm, 95% confidence interval 0.6 to 2.8 mm, p<0.01). There were no significant differences in mean trans-stenotic pressure gradient and mean eccentricity ratio between the initial and repeat angioplasty procedures.In individual patients the changes in stenosis morphology were unpredictable, but overall stenoses tended to be longer at restenosis. In some patients stenosis length increased by several millimetres but the success rate of repeat angioplasty was high and the clinical importance of the changes in stenosis morphology are uncertain.

Reversible occlusion of a side branch and the left anterior descending coronary artery following angioplasty

A 61-year-old man with unstable angina underwent emergency angioplasty of a proximal left anterior descending coronary stenosis. This was successful but a major first septal branch involved in the stenosis was occluded following the procedure. Recovery was uncomplicated, however, without chest pain or other evidence of myocardial infarction. Predischarge treadmill stress testing was negative for ischaemia but two hours afterwards abrupt coronary occlusion required a second emergency angioplasty procedure. Recanalization of the left anterior descending artery was achieved and the first septal branch was shown to be fully patent. Spasm probably accounted for the side branch occlusion which complicated the first procedure but the mechanism of the abrupt coronary occlusion following stress-testing is unclear.